Spirax Deferred Long Term Liab from 2010 to 2024
| SPX Stock | 7,160 260.00 3.77% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 12.3 M | Current Value 8.6 M | Quarterly Volatility 1.7 M |
Check Spirax Sarco financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spirax Sarco's main balance sheet or income statement drivers, such as Depreciation And Amortization of 101.8 M, Interest Expense of 53.8 M or Total Revenue of 1.8 B, as well as many indicators such as . Spirax financial statements analysis is a perfect complement when working with Spirax Sarco Valuation or Volatility modules.
Spirax | Deferred Long Term Liab |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Spirax Stock
Spirax Sarco financial ratios help investors to determine whether Spirax Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spirax with respect to the benefits of owning Spirax Sarco security.